Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination

Trends in Parasitology
Timothy N C WellsJ Kevin Baird

Abstract

Plasmodium vivax is the major species of malaria parasite outside Africa. It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver. Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance. However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine. This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment. New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda. New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites. This search is urgent, given the time needed to develop a new medication.

References

Mar 20, 2003·Trends in Parasitology·J Kevin Baird, Karl H Rieckmann
Jun 3, 2004·The Lancet Infectious Diseases·Simon I HayRobert W Snow
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Audrey GegoDominique Mazier
Jun 15, 2006·Tropical Medicine & International Health : TM & IH·Christoph Josef HemmerEmil Christian Reisinger
Nov 1, 2006·Current Opinion in Infectious Diseases·Babu L Tekwani, Larry A Walker
Mar 3, 2007·The Journal of Infectious Diseases·William E Collins
Mar 21, 2007·Transactions of the Royal Society of Tropical Medicine and Hygiene·Nguyen Van Hoang DaoMichael D Edstein
Aug 9, 2007·Nature Reviews. Molecular Cell Biology·Francesco PampaloniErnst H K Stelzer
Sep 29, 2007·Bioorganic & Medicinal Chemistry Letters·Shuren ZhuYuliang Kong
Jan 9, 2008·Trends in Parasitology·Rachanee UdomsangpetchJetsumon Sattabongkot
Apr 24, 2008·Malaria Journal·Lena HuldénKari Heliövaara
May 3, 2008·Trends in Parasitology·Erica L Dahl, Philip J Rosenthal
Jun 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·David PlouffeElizabeth A Winzeler
Sep 10, 2008·Cell Host & Microbe·Samir YalaouiPatrick Froissard
Oct 18, 2008·Nature Reviews. Drug Discovery·Fernán AgüeroChristophe L M J Verlinde
Feb 20, 2009·Malaria Journal·Mary R Galinski, John W Barnwell
May 1, 2009·Clinical Pharmacology and Therapeutics·P Olliaro, T N C Wells

❮ Previous
Next ❯

Citations

Feb 11, 2014·Nature Medicine·Laurent DembéléDominique Mazier
Mar 8, 2014·Nature Medicine·John W Barnwell, Mary R Galinski
Jul 19, 2013·Parasitology·Jeremy N BurrowsPaul Willis
Apr 16, 2014·Malaria Journal·Katherine E BattleSimon I Hay
Jun 11, 2014·Parasites & Vectors·Narayani Prasad KarNutan Nanda
Jul 9, 2014·Journal of the American Society for Mass Spectrometry·Paulo J Amorim MadeiraM Rosário Bronze
Mar 20, 2015·Drug Delivery and Translational Research·Vishvesh M Joshi, Padma V Devarajan
Aug 19, 2014·Trends in Parasitology·Didier LeroyStéphanie Cherbuin
Apr 19, 2011·Malaria Journal·Lena Hulden, Larry Hulden
Oct 4, 2011·PLoS Pathogens·Emily R DerbyshireJon Clardy
Oct 12, 2011·Current Opinion in Infectious Diseases·Ric N PriceLorenz von Seidlein
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sophie H AdjalleyDavid A Fidock
Jan 11, 2012·Malaria Journal·Thinley YangzomVas Dev
Mar 15, 2012·Current Infectious Disease Reports·J Kevin Baird
Feb 1, 2013·Malaria Journal·Herdiana HerdianaWilliam A Hawley
Oct 9, 2013·Proceedings of the National Academy of Sciences of the United States of America·Rosemary RochfordLarry A Walker
Dec 14, 2011·Malaria Journal·Deepika FernandoSenaka Rajapakse
Aug 21, 2012·Malaria Journal·George K JohnRic N Price
Oct 16, 2013·European Journal of Medicinal Chemistry·Tiago RodriguesFrancisca Lopes
Mar 8, 2012·The Journal of Infectious Diseases·Filipa P da CruzMiguel Prudêncio
Feb 8, 2013·Nature Medicine·Louis H MillerThomas E Wellems
Jul 29, 2010·Journal of the History of Biology·Miles B Markus
Oct 7, 2010·Parasitology Research·Miles B Markus
Sep 2, 2011·Future Medicinal Chemistry·Jeremy N BurrowsDavid Waterson
Feb 14, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicolas SennIvo Mueller
Feb 19, 2016·Malaria Journal·Daniel Gonçalves, Patrick Hunziker
Oct 5, 2013·Expert Opinion on Drug Discovery·Jana HeldBenjamin Mordmüller
May 3, 2011·FEBS Letters·Ines PetersenMichael Lanzer
Jan 19, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Thabang Mokgethi-Morule, David D N'Da
May 29, 2012·Infectious Disease Clinics of North America·Behzad Nadjm, Ron H Behrens
Sep 8, 2011·Acta Tropica·James W KazuraIvo Mueller
Nov 3, 2010·Lancet·Richard G A FeachemRobert W Snow
May 25, 2013·British Journal of Clinical Pharmacology·Ann K MillerAndrew P Beelen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.